By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mitoconix Bio 



Ness Ziona      Israel
Phone: n/a Fax: n/a


SEARCH JOBS

Mitoconix Bio Ltd is pioneering a novel strategy to improving mitochondrial health as a disease-modifying therapeutic for neurodegenerative diseases. Mitoconix’ lead drug is a first-in-class inhibitor of pathological mitochondrial fragmentation and dysfunction with demonstrated in vivo efficacy in animal models of Huntington’s (HD) and Parkinson’s diseases (PD) and beneficial activity in patient-derived cells of HD, sporadic and genetic PD, and sporadic and genetic Alzheimer’s disease (AD).

YEAR FOUNDED:

August 2016

LEADERSHIP:

Founder: Daria Mochly-Rosen

CEO: Eyal Neria, PhD


Key Statistics


Email:
Ownership: Private

Web Site: Mitoconix Bio
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->